Latest filing published 24 Jun 2026 for INSMED Inc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael Alexander Smith (senior executive) discloses dealings in INSMED Inc to SEC (Form 4). Between 8 July 2021 and 22 June 2026, the trades on record add up to 38 filings.
The open-market record consists of 20 sales worth €4.6M, with no purchase. No amount is published for 1 filing, which the totals therefore leave out. The rest of the record consists of 10 share grants and 8 option exercises. So far in 2026, the count stands at no purchases and 5 sales.
The newest entry dates from 24 June 2026: an open-market sale, in INSMED Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 38 declarations